AAAAAA

   
Results: 1-12 |
Results: 12
Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogues of angiotensin II
Authors: Lindman, S Lindeberg, G Gogoll, A Nyberg, F Karlen, A Hallberg, A
Citation: S. Lindman et al., Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogues of angiotensin II, BIO MED CH, 9(3), 2001, pp. 763-772
Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study
Authors: Steiner, G Hamsten, A Hosking, J Stewart, D McLaughlin, P Gladstone, P Sole, M Syvanne, M Hamsten, A Camelon, K Schloegl, G Genest, J Reeves, F Savard, R Letarte, A Bellavance, N Touchette, J Latour, Y Marchand, P Rondeau, C Rivard-Gervais, N Belanger, A Hamel, D Dumas, R Sandri, M Morin, N Caponi, E Barbeau, C Gauthier, S Ooi, TC Davies, RF Braaten, JT Baker, A Favreau, C Collar, C Zinman, B Gladstone, P Aldridge, H Donat, DJ Tsui, E Barnie, A DiMonte, L MacLean, S Bond, M Camelon, K Martin, C Zawacki, R Dziuran, K Gouveia, MR Taskinen, MR Nieminen, M Nikkila, K Virtanen, K Makimattila, S Malmstrom, R Kohtamaki, H Jamsen, P Salo, A Puupponen, M Kesaniemi, A Ikaheimo, M Ukkola, O Salmela, P Savolainen, M Huikuri, H Airaksinen, J Koistinen, J Mannermaa, L Ukkola, L Ketonen, K Silaste, ML Salovaara, A Efendic, S Svane, B Hellekant, C Bavenholm, P Karlen, A Hadell, K Hamsten, A Franson, K Mohlkert, D Nordlander, R Ehrenstig, L Tan, MH Title, LM Johnstone, D Winch, S Higgins-Bowser, I Shlossberg, A Murdock, H Elliott, T Fung, A Jalbert, A Leung, S Turnbull, S Norman, E Valensi, P Farez, C Tavolaro, O Sachs, RN Sedjari, F Laakso, M Kettunen, R Eranen, J Lehto, S Raisanen, R Jantunen, A Valve, R Toivanen, A Frohlich, J Vannetta, H Bowden, F Seccombe, DW Ehnholm, C Gref, CG Ikonen, M Sundvall, J Seccombe, DW McGuinness, C Ho, A Hamilton, J Pritchard, H McLaughlin, P Gladstone, P Allard, N Bond, M Bui, S Van der Wal, H Hosking, J Davis, CE Tyroler, HA Stewart, D Curtis, RC Miles, M Khaltaev, N Sole, M Kirkeeide, R Frick, H Hata, Y Rifkind, B Zimmet, P Gent, M Schonfeld, G de Bono, D Reeves, F Carter, A Ansquer, JC Fraitag, B Guivarc'h, PH Irvine, A Jacovella, J Munoz, A Rode, H Yacine, A Asmar-Kristiansen, D Bonnefous, F Belanger, F Bond, M Brown, M DeLorme, L Galos, C Jenkins, R Lanoue, C Moussalli, R Murtomaki, E Zandomenighi, F
Citation: G. Steiner et al., Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study, LANCET, 357(9260), 2001, pp. 905-910
Competitive CYP2C9 inhibitors: Enzyme inhibition studies, protein homologymodeling, and three-dimensional quantitative structure-activity relationship analysis
Authors: Afzelius, L Zamora, I Ridderstrom, M Andersson, TB Karlen, A Masimirembwa, CM
Citation: L. Afzelius et al., Competitive CYP2C9 inhibitors: Enzyme inhibition studies, protein homologymodeling, and three-dimensional quantitative structure-activity relationship analysis, MOLEC PHARM, 59(4), 2001, pp. 909-919
Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatography
Authors: Lagerquist, C Beigi, F Karlen, A Lennernas, H Lundahl, P
Citation: C. Lagerquist et al., Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatography, J PHARM PHA, 53(11), 2001, pp. 1477-1487
Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors
Authors: Schaal, W Karlsson, A Ahlsen, G Lindberg, J Andersson, HO Danielson, UH Classon, B Unge, T Samuelsson, B Hulten, J Hallberg, A Karlen, A
Citation: W. Schaal et al., Synthesis and comparative molecular field analysis (CoMFA) of symmetric and nonsymmetric cyclic sulfamide HIV-1 protease inhibitors, J MED CHEM, 44(2), 2001, pp. 155-169
Characterization of a set of HIV-1 protease inhibitors using binding kinetics data from a biosensor-based screen
Authors: Hamalainen, MD Markgren, PO Schaal, W Karlen, A Classon, B Vrang, L Samuelsson, B Hallberg, A Danielson, UH
Citation: Md. Hamalainen et al., Characterization of a set of HIV-1 protease inhibitors using binding kinetics data from a biosensor-based screen, J BIOMOL SC, 5(5), 2000, pp. 353-359
Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin II
Authors: Lindman, S Lindeberg, G Nyberg, F Karlen, A Hallberg, A
Citation: S. Lindman et al., Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin II, BIO MED CH, 8(9), 2000, pp. 2375-2383
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: Correlation with fraction absorbed in humans
Authors: Danelian, E Karlen, A Karlsson, R Winiwarter, S Hansson, A Lofas, S Lennernas, H Hamalainen, MD
Citation: E. Danelian et al., SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: Correlation with fraction absorbed in humans, J MED CHEM, 43(11), 2000, pp. 2083-2086
Bicyclic tripeptide mimetics with reverse turn inducing properties
Authors: Johannesson, P Lindeberg, G Tong, WM Gogoll, A Karlen, A Hallberg, A
Citation: P. Johannesson et al., Bicyclic tripeptide mimetics with reverse turn inducing properties, J MED CHEM, 42(4), 1999, pp. 601-608
Angiotensin II analogues encompassing 5,9-and 5,10-fused thiabicycloalkanetripeptide mimetics
Authors: Johannesson, P Lindeberg, G Tong, WM Gogoll, A Synnergren, B Nyberg, F Karlen, A Hallberg, A
Citation: P. Johannesson et al., Angiotensin II analogues encompassing 5,9-and 5,10-fused thiabicycloalkanetripeptide mimetics, J MED CHEM, 42(22), 1999, pp. 4524-4537
Inhibitors of the C-2-symmetric HIV-1 protease: Nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2 ' side chains
Authors: Hulten, J Andersson, HO Schaal, W Danielson, HU Classon, B Kvarnstrom, I Karlen, A Unge, T Samuelsson, B Hallberg, A
Citation: J. Hulten et al., Inhibitors of the C-2-symmetric HIV-1 protease: Nonsymmetric binding of a symmetric cyclic sulfamide with ketoxime groups in the P2/P2 ' side chains, J MED CHEM, 42(20), 1999, pp. 4054-4061
Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach
Authors: Winiwarter, S Bonham, NM Ax, F Hallberg, A Lennernas, H Karlen, A
Citation: S. Winiwarter et al., Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach, J MED CHEM, 41(25), 1998, pp. 4939-4949
Risultati: 1-12 |